BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15131125)

  • 1. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
    Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
    J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
    Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
    Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium.
    Hiemstra PS; van Wetering S; Stolk J
    Eur Respir J; 1998 Nov; 12(5):1200-8. PubMed ID: 9864022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
    Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
    J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
    Adam C; Bieth JG
    FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recognition of alpha 1-antitrypsin-elastase and alpha 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein.
    Poller W; Willnow TE; Hilpert J; Herz J
    J Biol Chem; 1995 Feb; 270(6):2841-5. PubMed ID: 7852358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production.
    Van Wetering S; Mannesse-Lazeroms SP; Dijkman JH; Hiemstra PS
    J Leukoc Biol; 1997 Aug; 62(2):217-26. PubMed ID: 9261336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.
    Owen CA; Campbell MA; Sannes PL; Boukedes SS; Campbell EJ
    J Cell Biol; 1995 Nov; 131(3):775-89. PubMed ID: 7593196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin.
    Lomas DA; Stone SR; Llewellyn-Jones C; Keogan MT; Wang ZM; Rubin H; Carrell RW; Stockley RA
    J Biol Chem; 1995 Oct; 270(40):23437-43. PubMed ID: 7559504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neutrophil serine proteinases by suramin.
    Cadène M; Duranton J; North A; Si-Tahar M; Chignard M; Bieth JG
    J Biol Chem; 1997 Apr; 272(15):9950-5. PubMed ID: 9092534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.
    Sepper R; Konttinen YT; Ingman T; Sorsa T
    J Clin Immunol; 1995 Jan; 15(1):27-34. PubMed ID: 7759598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
    Owen CA; Campbell EJ
    J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proteinase: mucus proteinase inhibitor binding stoichiometry.
    Boudier C; Bieth JG
    J Biol Chem; 1992 Mar; 267(7):4370-5. PubMed ID: 1537827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-competition for binding of alpha 1-antitrypsin (alpha 1 AT)-elastase complexes to the serpin-enzyme complex receptor by other serpin-enzyme complexes and by proteolytically modified alpha 1 AT.
    Joslin G; Wittwer A; Adams S; Tollefsen DM; August A; Perlmutter DH
    J Biol Chem; 1993 Jan; 268(3):1886-93. PubMed ID: 8380581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
    Takagi M
    Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2.
    Mulligan MS; Desrochers PE; Chinnaiyan AM; Gibbs DF; Varani J; Johnson KJ; Weiss SJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11523-7. PubMed ID: 7903451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The degradation of human lung elastin by neutrophil proteinases.
    Reilly CF; Travis J
    Biochim Biophys Acta; 1980 Jan; 621(1):147-57. PubMed ID: 6153274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.